Corrigendum to “Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies” [Respir. Med. 109 (2015) 1155–1163]

The authors regret that in the Abbreviations the following term, ‘long-acting muscarinic agonist’, should appear as ‘long-acting muscarinic antagonist’.

Source: Respiratory Medicine CME - September 29, 2015 Category: Respiratory Medicine Authors: Thomas M. Siler, Edward Kerwin, Ana R. Sousa, Alison Donald, Rehan Ali, Alison Church Tags: Corrigendum Source Type: research